Cargando…

Serum β-klotho is a potential biomarker in the prediction of clinical outcomes among patients with NSCLC

BACKGROUND: We aimed to investigate the β-klotho (KLB) expression in non-small cell lung cancer (NSCLC) and to determine its value as a novel molecular target for survival prognosis in patients with NSCLC. METHODS: The serum KLB concentrations in 50 patients with NSCLC and the 20 healthy persons wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Juan, Ben, Suqin, Xu, Tan, Xu, Liqin, Yao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182533/
https://www.ncbi.nlm.nih.gov/pubmed/34164204
http://dx.doi.org/10.21037/jtd-21-798

Ejemplares similares